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SUMMARY 
 
In this paper, a workflow within the VPH-DARE@IT Clinical Research Platform is presented. This 
is used to model the biomechanical behaviour of perfused brain tissue. This workflow features a 3D 
multicompartmental poroelastic framework, patient-specific brain anatomy representations and 
continuous waveforms of internal carotid and vertebral arteries, which are used as a means of 
personalizing the boundary conditions that feed the arterial compartment of the in-house 
poroelastic solver. Results are shown comparing CSF/ISF clearance and accumulation in two males 
of similar age, both are non-smokers, however one is more active and is diagnosed with MCI and 
experiences less sleep.  
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1   INTRODUCTION 
 
Dementia is a general term for a range of progressive, organic brain diseases that are characterized 
by problems of short-term memory, disturbances in language, psychological changes, psychiatric 
changes and lifestyle impairments [1-3].  
 Forty-six million people currently live with dementia [4], whilst by 2050, this number is 
expected to rise to 132 million [5]. The estimated cost of Dementia will increase from $818 billion 
in 2015 to over $1,000 billion by 2018 [5].  
 Mild cognitive impairment (MCI) is defined as a state between normal aging and dementia. 
It is defined as objective cognitive impairment relative to the person’s age, with concern about the 
cognitive symptoms, in a person with essentially normal functional activities who does not have 
dementia [6]. It affects 19% of people age 65 and over [7]. Around 46% of people with MCI 
develop dementia within 3 years, compared with 3% of the age-matched population [8]. 
 The capability to model transport of the fluid content of the brain, in a personalised manner 
and from first principles, is essential for enhancing the biomechanical understanding of functional 
features like perfusion and clearance. This understanding is expected to yield novel information 
(and novel biomarkers) especially regarding early stages of diseases of old age, such as dementia. 
 In this paper, we describe a consolidated pipeline which embeds the following: (i) the three 
dimensional finite element based discretization of the multiple-network poroelastic theory (MPET), 
(ii) MRI image acquisition, segmentation, surface correction, smoothing and ultimately mesh 
generation of the parenchymal and cerebroventricular volumes and finally, (iii) a subject-specific 
boundary condition model consisting of a coupled lumped parameter circulation model, surrogate 
model and cerebral autoregulation model. 
2  METHODOLOGY 
 
2.1 Multiple-Network Poroelastic Theory (MPET) 
 
MPET is used to develop a spatio-temporal model of tissue displacement and fluid regulation in 
varying scales within the cerebral environment. The field equations are discretized using the finite-
element method, and in all three spatial dimensions. 
 Specifically, the field equations of the MPET system stem from the fully dynamic, classical 
Biot system [9]. For a single compartment, this consists of the Navier equation representing 
momentum balance, and the Duhamel equation for the mass balance representing the diffusive 
Darcy fluid flow: 
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In equations 1a and 1b, ρ represents the density of a porous and permeable matrix, ρf represents the 
density of the fluid, λ and μ are the Lamé parameters (dilation and shear moduli of elasticity), α is 
the Biot-Willis constant, κ is the symmetric permeability tensor divided by the fluid viscosity, γ is 
the constrained specific storage coefficient, g is the gravity vector, s is a source/sink term and 
finally, u and p are the solid matrix displacement (mean displacement of particles forming the solid 
matrix) and the scalar pore pressure, respectively. 
 In its current form, the MPET model comprises of four separate fluid compartments, 
arterial blood (a), arteriole/capillary blood (c), venous blood (v) and CSF/ISF (e) [9]. The resulting 
MPET system is: 
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In the above equations, the fluid phase continuity equations include the sum of all interporosity 
fluxes (sxy), from network y to x. Here, the transfer is considered to be driven by a hydrostatic 
pressure gradient (of the form,  xy xy y xs p p  ), where ωxy is the transfer coefficient scaling the 
flow from network y to network x. 
 
2.2 Verification of MPET poroelastic solver 
 
In order to ascertain the accuracy of the 3D MPET poroelastic solver, the numerical code is verified 
against two consolidation problems, i.e. Terzaghi’s and Mandel’s [10,11] problems, respectively. In 
both of these simulations, a special case of the MPET system is utilized, specifically that of using a 
single compartment. Excellent agreement exists between the analytical and numerical solutions. 
 
 
 
 
 
 
 
 
 
Figure 1. Terzaghi’s 1D consolidation problem: (Left) Plots of dimensionless pore pressure against dimensionless vertical 
distance. (Center) Plots of dimensionless vertical displacement against dimensionless vertical distance. Mandel’s 2D 
consolidation problem: (Right) Plots of dimensionless pore pressure against dimensionless horizontal distance from the 
center. Coloured curves represent the analytical solutions in all three plots. 
2.3 Consolidated pipeline 
 
A depiction of the consolidated pipeline can be seen in Figure 2 below. The personalization of the 
cerebral geometries is achieved by a separate pipeline that comprises of: (i) Image segmentation of 
sub-cortical and whole brain segmentation of T1-weighted images, (ii) Diffusion tensor field 
estimation, (iii) Image registration, (iv) volumetric mesh generation and (v) permeability tensor 
field interpolation.  
 The second integral component of the consolidate pipeline involves an overarching 
subject-specific boundary condition model, intricately consisting of a lumped parameter circulation 
model, surrogate model and cerebral autoregulation model. This component yields subject specific 
boundary condition profiles for the arterial compartment of the MPET system, and is able to 
provide subject-specific measurements of internal carotid and vertebral artery flow in both left and 
right sides of the cerebrum and cerebellum. These values are divided by the surface area of each 
corresponding surface region (left/right cerebellum/cerebrum) and subsequently converted into a 
Neumann boundary condition via the use of the porosity of the arterial compartment. This 
ultimately gives rise to a detailed atlas of voxel specific arterial pore pressures, which have been 
directly influenced by the adoption of the feeding territories as boundary conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Consolidated poroelastic pipeline. 
 
3 RESULTS AND CONCLUSIONS 
 
In Figure 3 below, a sample of the type of results that can be investigated in detail are shown. The 
below results correspond to a period of high activity for both MCI patient and control subject. In 
this set of results, Control 18 corresponds to a 77-year-old male, non-smoker, weighing 64 kg and 
has stated that he spends between 15-29 minutes per day on leisure activities and an average 
sleeping pattern. MCI 16 is a 78-year-old male with MCI, a non-smoker, weighing 70 kg, spends 
over 1 hour on his daily leisure whilst only achieving just under 6 hours of sleep. The CSF/ISF 
clearance corresponds to the Darcy filtration velocity of the CSF/ISF compartment, whilst CSF/ISF 
accumulation corresponds to the fluid increment in the same compartment. Periventricularly, it can 
be seen in Figure 3 that clearance of CSF/ISF is high, with the MCI patient exhibiting a lower peak 
CSF/ISF clearance of ~ 0.8 µm/s compared to ~ 5 µm/s for the control subject in the deep 
parenchyma. Both control and MCI cases appear to have a similar peak clearance rate of ~ 1 cm/s.   
 For the results allied to CSF/ISF accumulation, it is observed that fluid tends to accumulate 
around the ventricles yet also exhibits peak drainage at the ventricular areas of highest concavity. 
The MCI patient accumulates and drains more CSF/ISF compared to the healthy case, even though 
the ventricular volume is smaller for the MCI patient. This qualitatively agrees with previous 
results [9]. Periventricular lucency (PVL) [12] is represented by increased CSF/ISF content in the 
periventricular regions, and is stipulated to be a result of ependymal surface breakdown. In theory, 
this helps alleviate some of the increased pressure in the ventricles by allowing for some CSF 
extravasation and subsequently edema formation (frontal horns, where peak drainage occurs). This 
mechanism could be achieved with the possible assistance of Aquaporin-4 [13], which lines the 
ependymal surface. Peña and colleagues [14] describe how the concavity of the ventricles helps 
accumulate expansive stresses on the horns of the ventricles, which as is now known could induce 
swelling activated Cl− channels such in microglia, and therefore facilitate periventricular lucency 
[15,16].  
 Results corresponding to a period of low activity (sleep) for the same subject and patient 
show a CSF/ISF clearance (range of ~ 1cm/s to ~ 5 µm/s) and fluid accumulation (2.35 to -0.2) for 
the healthy case, and a range of ~ 7 mm/s to ~ 0.3 µm/s and 2.66 to -1.15 for the MCI patient 
respectively. This type of comparison may assist in the interrogation of whether a paravascular 
pathway facilitates the clearance of solutes from the brain parenchyma, as it has been shown that 
mice lacking astrocytic Aquaporin-4 exhibit reduced solute clearance (such as amyloid-β). This 
type of modelling could therefore aid in providing valuable information allied to disease 
progression in Alzheimer’s disease [17]. Other sets of results currently being scrutinized include a 
healthy 82-year-old female and an 83-year-old female with MCI and two 66-year-old males 
(control and MCI).   
 
 
    
 
 
 
 
 
 
 
 
 
   
Figure 3. CSF/ISF clearance (left pair) and CSF/ISF accumulation (right pair) results for the control (C18) 
and MCI (MCI16) case respectively.   
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